Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

925 publication(s) found matching the search criteria

Clinical practice guidelines for the care of girls and women with Turner syndrome


Author(s): Gravholt CH, Andersen NH, Christin-Maitre S, Davis SM, Duijnhouwer A, Gawlik A, Maciel-Guerra AT, Gutmark-Little I, Fleischer K, Hong D, Klein KO, Prakash SK, Shankar RK, Sandberg DE, Sas TCJ, Skakkebæk A, Stochholm K, van der Velden JA, Alvarez-Nava F, Avdic HB, Balle CM, Bamba V, Bedei I, Bonnard Ã, Brickman WJ, Brown NM, Chernausek S, Cobbold J, Corathers SD, Corpechot C, Crenshaw ML, Davies M, Deeb A, Dessens A, Dowlut-McElroy T, Elliott V, Fadoju D, Fechner PY, Geffner M, Gitomer S, de Groote K, Hewitt J, Ho C, Hutaff-Lee C, Isojima T, Johannsen EB, Kawai M, Keselman A, Knickmeyer RC, Kremen J, Kristrøm B, Kruszka P, Law J, Lin AE, Loechner K, Mauras N, Matthews D, Mikkelborg T, Mortensen KH, Nahata L, Norman M, Patel SR, Quigley C, Ridder LO, Santen RJ, Sheanon N, Smyth A, Turner H, Verlinde F, Viuff MH, Wasniewska M, van der Weijde B, Woelfle J, Wolstencroft J, Backeljauw PF
Affiliated Institution / ERN: Aarhus University Hospital ; Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: 45,X
Publication: European Journal of Endocrinology v190.6 pG53-G151 Year: 2024 ORPHAcode / other: ORPHA881
DOI: 10.1093/ejendo/lvae050 Keywords: Turner syndrome,cardiovascular health,co-morbidity,hypogonadism,infertility,neurocognition,transition
MTG7

Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion


Author(s): Biagetti B, Araujo-Castro M, Torre EM, Novoa-Testa I, Cordido F, Corrales EP, Berrocal VR, Guerrero-Pérez F, Vicente A, Percovich JC, Centeno RG, González L, García MDO, Echarri AI, Rodríguez MDM, Novo-Rodríguez C, Calatayud M, Villar-Taibo R, Bernabéu I, Alvarez-Escola C, Valderrama PB, Tenorio-Jiménez C, Galiana PA, Moreno EV, Molero IG, Iglesias P, Blanco C, De Lara FV, de Miguel P, Mezquita EL, Hanzu F, Aldecoa I, Aznar S, Lamas C, Aulinas A, Asla Roca Q, Gracia P, Córdova JMR, Aviles M, Asensio-Wandosel D, Sampedro M, Cámara R, Paja M, Ruz-Caracuel I, Fajardo-Montañana C, Asanza EC, Martinez-Saez E, Marazuela M, Puig-Domingo M
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitari Vall d’Hebron ; Complejo Hospitalario Regional Virgen del Rocio ;
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v190.6 p458-466 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1093/ejendo/lvae053 Keywords: acromegaly,cabergoline,dopamine agonist,first-line treatment,prolactin,somatostatin receptor ligand
MTG6

Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study


Author(s): Sampedro-Nuñez M, Herrera-Martínez AD, Ibáñez-Costa A, Rivero-Cortés E, Venegas E, Robledo M, Martínez-Hernández R, García-Martínez A, Gil J, Jordà M, López-Fernández J, Gavilán I, Maraver S, Marqués-Pamies M, Cámara R, Fajardo-Montañana C, Valassi E, Dios E, Aulinas A, Biagetti B, Álvarez Escola C, Araujo-Castro M, Blanco C, Paz dM, Villar-Taibo R, Álvarez CV, Gaztambide S, Webb SM, Castaño L, Bernabéu I, Picó A, Gálvez M, Soto-Moreno A, Puig-Domingo M, Castaño JP, Marazuela M, Luque RM, Adrados M, Flores PM, Leví AMR, Serrano-Somavilla A, Díez JJ, Villanueva MG, Iglesias P, Berrocal VR, Gutiérrez EA, Bances L, Calvo Gracia FL, Comunas F, López IQ, Hernando CA, Luis JMP, Centeno RG, Iza B, López CP, Zamarrón ÃP, Alén JF, Gutiérrez MC, Sansinenea IP, Otero Ã, Córdova JMR, Sousa P, Belinchón J, Herguido MJ, de Lope ÃR, Delgado AV, Muñoz F, Santos A, Asla Q, Servat AS, Torres A, Vidal N, Villabona C, Sesmilo G, Cambra GC, Obiols G, Carrato C, Salinas I, Hostalot C, Blanco A, Zabala R, Simón I, Ibáñez J, Fernández HG, Serra G, Riesgo P, Simal-Julian JA, Lamas C, Sandoval H, Abarca J, Mendoza NA, Ortiga RS, Monjas I, Font TP, Troncoso IA, Catalina PF, San Martín RMÃ, Ballesteros Pomar MD, Romero SP, Rodríguez EF, García-Allut A, Serramito R, Prieto A, Bellas LC, Pardo JIV, Expósito MRA, Moreno-Moreno P, Padillo-Cuenca JC, Vázquez-Borrego MC, Fuentes-Fayos AC, Leal-Cerro A, Japón MÃ, Rivera NG, Arnés JAG, González-Molero I, Maraver-Selfa S, Vela ET, Avilés-Pérez MD, Tenorio-Jiménez C, Carazo AM, García JGO
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitario Cruces ; Complejo Hospitalario Regional Virgen del Rocio ; Hospital Universitari Vall d’Hebron ;
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v190.6 p421-433 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1093/ejendo/lvae045 Keywords: REMAH study,combined molecular and clinical biomarkers,curation,pituitary tumor,transsphenoidal surgery
MTG6

Molecular mechanisms of human overgrowth and use of omics in its diagnostics: chances and challenges


Author(s): Prawitt D, Eggermann T
Affiliated Institution / ERN: University Hospital Aachen ; University Medical Center Mainz ;
Condition / Disease: Beckwith-Wiedemann Syndrome
Publication: Frontiers in Genetics v15 Year: 2024 ORPHAcode / other: ORPHA116
DOI: 10.3389/fgene.2024.1382371 Keywords: diagnostics,long read sequencing,massive parallel sequencing (MPS),mosaicism,omics,overgrowth
MTG5

A Novel De novo Heterozygous Mutation in the SON Gene Associated with Septo-optic Dysplasia: A New Phenotype


Author(s): Pasca L, Politano D, Cavallini A, Panzeri E, Vigone MC, Baldoli C, Abbate M, Kullmann G, Marelli S, Pozzobon G, Vincenzi G, Nacinovich R, Bassi MT, Romaniello R
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Septo-optic Dysplasia
Publication: Neuropediatrics v55.03 p191-195 Year: 2024 ORPHAcode / other: ORPHA3157; ORPHA46; ORPHA95488;
DOI: 10.1055/a-2114-4387 Keywords:
MTG6

Primary Hypothyroidism in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review


Author(s): Milano MT, Vargo JA, Yorke ED, Ronckers CM, Kremer LC, Chafe SM, van Santen HM, Marks LB, Bentzen SM, Constine LS, Vogelius IR
Affiliated Institution / ERN: Amsterdam UMC ; University Medical Center Utrecht ; Copenhagen University Hospital, Rigshospitalet ;
Condition / Disease: Pediatric primary hypothyroidism
Publication: International Journal of Radiation Oncology*Biology*Physics v119.2 p482-493 Year: 2024 ORPHAcode / other:
DOI: 10.1016/j.ijrobp.2021.02.001 Keywords:
MTG8

Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism


Author(s): Vescini F, Borretta G, Chiodini I, Boniardi M, Carotti M, Castellano E, Cipriani C, Eller-Vainicher C, Giannini S, Iacobone M, Salcuni AS, Saponaro F, Spiezia S, Versari A, Zavatta G, Mitrova Z, Saulle R, Vecchi S, Antonini D, Basile M, Giovanazzi A, Paoletta A, Papini E, Persichetti A, Samperi I, Scoppola A, Novizio R, Calò PG, Cetani F, Cianferotti L, Corbetta S, De Rimini ML, Falchetti A, Iannetti G, Laureti S, Lombardi CP, Madeo B, Marcocci C, Mazzaferro S, Miele V, Minisola S, Palermo A, Pepe J, Scillitani A, Tonzar L, Grimaldi F, Cozzi R, Attanasio R
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; IRCCS Auxologico Italian Institute - Milan ; University Hospital of Padova ; AOU Pisan ; AOU-Bologna ; University Hospital Florence ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Hyperparathyroidism
Publication: Endocrine, Metabolic & Immune Disorders - Drug Targets v24.8 p991-1006 Year: 2024 ORPHAcode / other: ORPHA181408
DOI: 10.2174/0118715303260423231122111705 Keywords:
MTG2

Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management


Author(s): Grottoli S, Maffei P, Tresoldi AS, Granato S, Benedan L, Mariani P, Giustina A
Affiliated Institution / ERN: San Raffaele hospital - Milan ; AO City of Health and Science - Turin ;
Condition / Disease: Acromegaly
Publication: Journal of Endocrinological Investigation v47.12 p2999-3017 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1007/s40618-024-02386-3 Keywords: Acromegaly,Delphi,Pasireotide,Pegvisomant,Somatostatin receptor ligands (SRLs),Type 2 diabetes mellitus
MTG6

Cardiac magnetic resonance reveals biventricular impairment in Cushing’s syndrome: a multicentre case-control study


Author(s): Feola T, Cozzolino A, De Alcubierre D, Pofi R, Galea N, Catalano C, Simeoli C, Di Paola N, Campolo F, Pivonello R, Isidori AM, Giannetta E
Affiliated Institution / ERN: AOU Federico II - Naples ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Cushing syndrome due to cortisol-producing adrenocortical adenoma
Publication: Endocrine v85.2 p937-946 Year: 2024 ORPHAcode / other: ORPHA647758
DOI: 10.1007/s12020-024-03856-7 Keywords: Cardiac magnetic resonance,Cardiomyopathy,Cushing’s syndrome,Glucocorticoid,Heart,Hypercortisolism
MTG1

Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population


Author(s): Marconi M, Pagano MT, Ristori J, Bonadonna S, Pivonello R, Meriggiola MC, Motta G, Lombardo F, Mosconi M, Oppo A, Cocchetti C, Romani A, Federici S, Bruno L, Verde N, Lami A, Crespi CM, Marinelli L, Giordani L, Matarrese P, Ruocco A, Santangelo C, Contoli B, Masocco M, Minardi V, Chiarotti F, Fisher AD, Pierdominici M
Affiliated Institution / ERN: AOU Federico II - Naples ; IRCCS Auxologico Italian Institute - Milan ; University Hospital Florence ; AO City of Health and Science - Turin ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Transgender, female to male
Publication: Journal of Endocrinological Investigation v47.11 p2851-2864 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1007/s40618-024-02362-x Keywords: Binary,Cancer screening,General health,Non-binary,Prevention,Transgender
MTG7

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs


Author(s): Araujo-Castro M, Biagetti B, Menéndez Torre E, Novoa-Testa I, Cordido F, Pascual-Corrales E, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Percovich Hualpa JC, García-Centeno R, González-Fernández L, Ollero García MD, Irigaray Echarri A, Moure Rodríguez MD, Novo-Rodríguez C, Calatayud M, Villar-Taibo R, Bernabéu I, Alvarez-Escola C, Benítez Valderrama P, Tenorio-Jiménez C, Abellán Galiana P, Venegas E, González-Molero I, Iglesias P, Blanco-Carrera C, Vidal-Ostos De Lara F, de Miguel Novoa P, López Mezquita E, Hanzu FA, Aldecoa I, Aznar S, Lamas C, Aulinas A, Asla Q, Gracia Gimeno P, Recio-Córdova JM, Avilés-Pérez MD, Asensio-Wandosell D, Sampedro-Núñez M, Cámara R, Paja Fano M, Ruz-Caracuel I, Fajardo C, Marazuela M, Puig-Domingo M
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitari Vall d’Hebron ; Complejo Hospitalario Regional Virgen del Rocio ;
Condition / Disease: Acromegaly
Publication: Endocrine-Related Cancer v31.7 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1530/ERC-24-0043 Keywords: acromegaly,pasireotide,pegvisomant,pituitary neuroendocrine tumors,prolactin
MTG6

Treatment trajectories of gender incongruent Austrian youth seeking gender-affirming hormone therapy


Author(s): Steininger J, Knaus S, Kaufmann U, Ott J, Riedl S
Affiliated Institution / ERN: Medical University of Vienna,Center for Disorders of Sex Development / Dpt. of Pediatrics ;
Condition / Disease: Transgender, female to male
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.3389/fendo.2024.1258495 Keywords: fertility preservation,gender-affirming care,hormone therapy,legal gender marker,transgender
MTG7

European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency


Author(s): Felix Beuschlein, Tobias Else, Irina Bancos, Stefanie Hahner, Oksana Hamidi, Leonie van Hulsteijn, Eystein S Husebye, Niki Karavitaki, Alessandro Prete, Anand Vaidya, Christine Yedinak, Olaf M Dekkers
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: European Journal of Endocrinology Volume 190, Issue 5 Year: 2024 ORPHAcode / other: ORPHA418; ORPHA96253; ORPHA647758; ORPHA189427; ORPHA314749;
DOI: 10.1093/ejendo/ivad008 Keywords: Adrenal insufficiency, glucocorticoids, steroids, adrenal crisis, substitution therapy, glucocorticoid withdrawal
MTG1 MTG6

The behavioral component of sexual inhibition and its relation with testosterone levels: An fMRI study in transgender and cisgender individuals


Author(s): Kennis M, Dewitte M, T’Sjoen G, Stinkens K, Sack A, Duecker F
Affiliated Institution / ERN: Ghent University Hospital ; Maastricht University Medical Center+ ;
Condition / Disease: Transgender, female to male
Publication: Psychoneuroendocrinology v163 p106963 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1016/j.psyneuen.2024.106963 Keywords:
MTG7

Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center


Author(s): Neocleous V, Fanis P, Toumba M, Skordis N, Phylactou LA
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Orphanet Journal of Rare Diseases v19.1 Year: 2024 ORPHAcode / other: ORPHA418
DOI: 10.1186/s13023-024-03171-4 Keywords: MKRN3,RET,CAH,DSD,ENDO-ERN,Endocrine disorders,MEN2,MODY
MTG4 MTG7

The effect of coping strategies on health–related quality of life in acromegaly patients


Author(s): Schock L, Chmielewski WX, Siegel S, Detomas M, Deutschbein T, Giese S, Honegger J, Unger N, Kreitschmann-Andermahr I
Affiliated Institution / ERN: University Hospital Essen ; University Hospital Würzburg ; Universitätsklinikum Tübingen ;
Condition / Disease: Acromegaly
Publication: Endocrine v84.3 p1108-1115 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1007/s12020-024-03813-4 Keywords:
MTG6

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey


Author(s): Cherenko M, Appelman-Dijkstra NM, Priego Zurita AL, Biermasz NR, Dekkers OM, Klok FA, Reisch N, Aulinas A, Biagetti B, Cannavo S, Canu L, Detomas M, Devuyst F, Falhammar H, Feelders RA, Ferrau F, Gatto F, Grasselli C, van Houten P, Hoybye C, Isidori AM, Kyrilli A, Loli P, Maiter D, Nowak E, Pivonello R, Ragnarsson O, Steenaard RV, Unger N, van de Ven A, Webb SM, Yeste D, Ahmed SF, Pereira AM
Affiliated Institution / ERN: Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; Amsterdam UMC ;
Condition / Disease: Cushing disease
Publication: Endocrine Connections v13.6 Year: 2024 ORPHAcode / other: ORPHA96253
DOI: 10.1530/EC-24-0046 Keywords: Cushing disease,Cushing syndrome,endogenous hypercortisolism,thromboprophylaxis,venous thromboembolism
MTG6

Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres


Author(s): Dwyer AA, McDonald IR, Cangiano B, Giovanelli L, Maione L, Silveira LFG, Raivio T, Latronico AC, Young J, Quinton R, Bonomi M, Persani L, Seminara SB, Lee CS
Affiliated Institution / ERN: IRCCS Auxologico Italian Institute - Milan ; Hôpital Bicêtre ; Helsinki University Hospital (HUS) ;
Condition / Disease: Kallmann Syndrome
Publication: The Lancet Diabetes & Endocrinology v12.4 p257-266 Year: 2024 ORPHAcode / other: ORPHA478
DOI: 10.1016/S2213-8587(24)00028-7 Keywords:
MTG7

Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors


Author(s): Ruggeri RM, Aini I, Gay S, Grossrubatscher EM, Mancini C, Tarsitano MG, Zamponi V, Isidori AM, Colao A, Faggiano A
Affiliated Institution / ERN: AOU Federico II - Naples ; AOU Policlinico Umberto I - Rome ; AOU polyclinic "G.Martino" of Messina ;
Condition / Disease: Multiple endocrine neoplasia type 1
Publication: Reviews in Endocrine and Metabolic Disorders v25.2 p383-398 Year: 2024 ORPHAcode / other: ORPHA652
DOI: 10.1007/s11154-023-09858-6 Keywords: Gender,Neuroendocrine neoplasms,PRRT,Somatostatin analogues (SSA),Somatostatin receptors (SSTR),Therapy
MTG4

Exploring sexual function in adrenal insufficiency: findings from the Dual RElease hydrocortisone versus conventionAl glucocorticoid replaceMent therapy in hypocortisolism (DREAM) trial


Author(s): Hasenmajer V, De Alcubierre D, Ferrari D, Minnetti M, Bonaventura I, Pofi R, Simeoli C, Tomaselli A, Sciarra F, Bottillo G, Angelini F, Cozzolino A, Venneri MA, Jannini EA, Gianfrilli D, Pivonello R, Isidori AM
Affiliated Institution / ERN: AOU Federico II - Naples ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Chronic adrenocorticoid insufficiency
Publication: Andrology doi:10.1111/andr.13635 Year: 2024 ORPHAcode / other: ORPHA101959
DOI: 10.1111/andr.13635 Keywords: adrenal insufficiency,dual‐release hydrocortisone,erectile dysfunction,sexual function
MTG1

A European Network for the Investigation of Gender Incongruence in adolescents


Author(s): Boogers LS, Wiepjes CM, Staphorsius AS, Klink DT, Ciancia S, Romani A, Stolk THR, van den Boogaard E, Steensma TD, de Vries ALC, van Trotsenburg ASP, den Heijer M, Fisher AD, Cools M, Hannema SE
Affiliated Institution / ERN: Ghent University Hospital ; University Hospital Florence ; Amsterdam UMC ;
Condition / Disease: Transgender, female to male
Publication: The Journal of Sexual Medicine v21.4 p350-356 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1093/jsxmed/qdae014 Keywords: GAH,GnRHa,adolescent,estradiol,puberty,testosterone,transgender
MTG7

Increased risk of nephrolithiasis: an emerging issue in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency


Author(s): Chiarito M, Lattanzio C, D’Ascanio V, Capalbo D, Cavarzere P, Grandone A, Aiello F, Pepe G, Wasniewska M, Zoller T, Salerno M, Faienza MF
Affiliated Institution / ERN: AOU Federico II - Naples ; AOUI Verona ; AOU polyclinic "G.Martino" of Messina ; AOU University of Campania "Luigi Vanvitelli", Naples ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Endocrine v84.2 p727-734 Year: 2024 ORPHAcode / other: ORPHA418
DOI: 10.1007/s12020-024-03792-6 Keywords: 17-OHP,21-hydroxylase deficiency (21-OHD),ACTH,Congenital adrenal hyperplasia (CAH),Nephrolithiasis
MTG7

IGF‐1 as screening tool for acromegaly and adult‐onset growth hormone deficiency in the Netherlands


Author(s): Postma MR, van Beek AP, van der Klauw MM, Lentjes EGWM, Muller Kobold AC
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Pituitary
Publication: Clinical Endocrinology v100.3 p260-268 Year: 2024 ORPHAcode / other: ORPHA963; ORPHA95502;
DOI: 10.1111/cen.15000 Keywords: IGF-1,acromegaly,adult-onset growth hormone deficiency
MTG6

Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial


Author(s): Baudin E, Goichot B, Berruti A, Hadoux J, Moalla S, Laboureau S, Nölting S, de la Fouchardière C, Kienitz T, Deutschbein T, Zovato S, Amar L, Haissaguerre M, Timmers H, Niccoli P, Faggiano A, Angokai M, Lamartina L, Luca F, Cosentini D, Hahner S, Beuschlein F, Attard M, Texier M, Fassnacht M, DOCAO C, Drui D, Borson Chazot F, Chabre O, Vezzosi D, Castinetti F, Bertherat J, Libé R, Gimenez-Roqueplo AP, Favier J, Quinkler M, Strasburger C, Zopf K, Reincke M, Kroiss M, Remde H, Haaf M, Fuß CT, Dischinger U, Eisenhofer G, Pamporaki C, Van Berkel A
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ;
Condition / Disease: Sporadic phaeochromocytoma/secreting paraganglioma
Publication: The Lancet v403.10431 p1061-1070 Year: 2024 ORPHAcode / other: ORPHA276621
DOI: 10.1016/S0140-6736(23)02554-0 Keywords:
MTG1

Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults


Author(s): Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M’Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM
Affiliated Institution / ERN: Hôpital Bicêtre ;
Condition / Disease: Hypophosphatasia
Publication: Osteoporosis International v35.3 p431-438 Year: 2024 ORPHAcode / other: ORPHA436
DOI: 10.1007/s00198-023-06844-1 Keywords: Diagnosis,Hypophosphatasia,Major criteria,Minor criteria
MTG2

The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance


Author(s): Brandi ML, Khan AA, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M’Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Roux C
Affiliated Institution / ERN: Hôpital Bicêtre ;
Condition / Disease: Hypophosphatasia
Publication: Osteoporosis International v35.3 p439-449 Year: 2024 ORPHAcode / other: ORPHA436
DOI: 10.1007/s00198-023-06859-8 Keywords: Diagnostic parameters,HPP diagnosis in adults,Hypophosphatasia,Systematic review
MTG2

Changes in depression symptom profile with gender-affirming hormone use in transgender persons


Author(s): Morssinkhof MW, Wiepjes CM, van den Heuvel OA, Kreukels BP, van der Tuuk K, T'Sjoen G, den Heijer M, Broekman BF
Affiliated Institution / ERN: Ghent University Hospital ; Amsterdam UMC ; University Medical Center Groningen ;
Condition / Disease: Transgender, female to male
Publication: Journal of Affective Disorders v348 p323-332 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1016/j.jad.2023.12.056 Keywords: Depression,Estrogen,Gender affirming hormone therapy,Testosterone,Transgender
MTG7

Near Adult Height and Body Mass Index Changes in Growth Hormone Treated Short Children with Noonan Syndrome: The Belgian Experience


Author(s): De Schepper J, Thomas M, Huysentruyt K, Becker M, Boros E, Casteels K, Chivu O, De Waele K, Dotremont H, Lysy PA, Massa G, Parent A, Rochtus A, Gies I
Affiliated Institution / ERN: Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; UZ Brussels ; University Hospitals Saint-Luc ; University Hospital Liège ; Ghent University Hospital ; UZ Antwerpen ; UZ Leuven ;
Condition / Disease: Noonan Syndrome
Publication: Hormone Research in Paediatrics p1-13 Year: 2024 ORPHAcode / other: ORPHA648
DOI: 10.1159/000538034 Keywords:
MTG5

IGF‐1 as screening tool for acromegaly and adult‐onset growth hormone deficiency in the Netherlands


Author(s): Postma MR, van Beek AP, van der Klauw MM, Lentjes EGWM, Muller Kobold AC
Affiliated Institution / ERN: University Medical Center Groningen ; University Medical Center Utrecht ;
Condition / Disease: Pituitary gigantism
Publication: Clinical Endocrinology v100.3 p260-268 Year: 2024 ORPHAcode / other: ORPHA99725
DOI: https://doi.org/10.1111/cen.15000 Keywords:
MTG6

Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS)


Author(s): Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, Mensenkamp AR, Brems H, de Putter R, Anastasiadou VC, Villy M, Jahn A, Steinke-Lange V, Baldassarri M, Irmejs A, de Jong MM, Links TP, Leter EM, Bosch DGM, Høberg-Vetti H, Tveit Haavind M, Jørgensen K, Mæhle L, Blatnik A, Brunet J, Darder E, Tham E, Hoogerbrugge N, Vos JR
Affiliated Institution / ERN: University Medical Center Groningen ; UZ Leuven ;
Condition / Disease: Partial gonadal dysgenesis
Publication: Cancers v16.5 p953 Year: 2024 ORPHAcode / other: NO XX CODE
DOI: 10.3390/cancers16050953 Keywords: alcohol drinking,body mass index,breast neoplasm,exercise,hamartoma syndrome,multiple
MTG7
Page 4 of 31« First«...23456...102030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance